96 related articles for article (PubMed ID: 21415775)
1. Clinical relevance of autoantibody detection in lung cancer.
Solassol J; Maudelonde T; Mange A; Pujol JL
J Thorac Oncol; 2011 May; 6(5):955-62. PubMed ID: 21415775
[TBL] [Abstract][Full Text] [Related]
2. [Autoantibodies against tumor-related antigens: new tools for early detection of lung cancer].
Solassol J; Harmand PO; Maudelonde T; Pujol JL
Bull Cancer; 2011 Dec; 98(12):1419-30. PubMed ID: 22146366
[TBL] [Abstract][Full Text] [Related]
3. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer.
Bradford TJ; Wang X; Chinnaiyan AM
Urol Oncol; 2006; 24(3):237-42. PubMed ID: 16678056
[TBL] [Abstract][Full Text] [Related]
4. [Serum autoantibodies profiling and early-stage cancer detection].
Desmetz C; Lacombe J; Mange A; Maudelonde T; Solassol J
Med Sci (Paris); 2011; 27(6-7):633-8. PubMed ID: 21718648
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to tumor-associated antigens in lung cancer diagnosis.
Zhang X; Liu M; Zhang X; Wang Y; Dai L
Adv Clin Chem; 2021; 103():1-45. PubMed ID: 34229848
[TBL] [Abstract][Full Text] [Related]
6. Rethinking Autoantibody Signature Panels for Cancer Diagnosis.
Campa MJ; Gottlin EB; Herndon JE; Patz EF
J Thorac Oncol; 2017 Jun; 12(6):1011-1014. PubMed ID: 28126538
[TBL] [Abstract][Full Text] [Related]
7. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer.
Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q
Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721
[TBL] [Abstract][Full Text] [Related]
8. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody profiling for cancer detection.
Qiu J; Hanash S
Clin Lab Med; 2009 Mar; 29(1):31-46. PubMed ID: 19389549
[TBL] [Abstract][Full Text] [Related]
10. A cancer/testis antigen microarray to screen autoantibody biomarkers of non-small cell lung cancer.
Shan Q; Lou X; Xiao T; Zhang J; Sun H; Gao Y; Cheng S; Wu L; Xu N; Liu S
Cancer Lett; 2013 Jan; 328(1):160-7. PubMed ID: 22922091
[TBL] [Abstract][Full Text] [Related]
11. Use of a combination of approaches to identify and validate relevant tumor-associated antigens and their corresponding autoantibodies in ovarian cancer patients.
Gagnon A; Kim JH; Schorge JO; Ye B; Liu B; Hasselblatt K; Welch WR; Bandera CA; Mok SC
Clin Cancer Res; 2008 Feb; 14(3):764-71. PubMed ID: 18245537
[TBL] [Abstract][Full Text] [Related]
12. A Low-density Antigen Array for Detection of Disease-associated Autoantibodies in Human Plasma.
Somiari RI; Sutphen R; Renganathan K; Russell S; Pastwa E; Somiari SA
Cancer Genomics Proteomics; 2016; 13(1):13-9. PubMed ID: 26708595
[TBL] [Abstract][Full Text] [Related]
13. Autoantibody diagnostics in clinical practice.
Conrad K; Roggenbuck D; Reinhold D; Sack U
Autoimmun Rev; 2012 Jan; 11(3):207-11. PubMed ID: 21621008
[TBL] [Abstract][Full Text] [Related]
14. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer.
Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G
Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620
[TBL] [Abstract][Full Text] [Related]
15. Development of autoantibody signatures for common cancers.
Kobayashi M; Katayama H; Fahrmann JF; Hanash SM
Semin Immunol; 2020 Feb; 47():101388. PubMed ID: 31924500
[TBL] [Abstract][Full Text] [Related]
16. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers.
Rom WN; Goldberg JD; Addrizzo-Harris D; Watson HN; Khilkin M; Greenberg AK; Naidich DP; Crawford B; Eylers E; Liu D; Tan EM
BMC Cancer; 2010 May; 10():234. PubMed ID: 20504322
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
Fernández Madrid F
Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
[TBL] [Abstract][Full Text] [Related]
19. Serologic autoantibodies as diagnostic cancer biomarkers--a review.
Zaenker P; Ziman MR
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2161-81. PubMed ID: 24057574
[TBL] [Abstract][Full Text] [Related]
20. Detection of tumor-specific autoantibodies in sera of patients with lung cancer.
Nagashio R; Sato Y; Jiang SX; Ryuge S; Kodera Y; Maeda T; Nakajima T
Lung Cancer; 2008 Dec; 62(3):364-73. PubMed ID: 18485524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
